Viral Eradication and Fibrosis Resolution in Post Liver Transplant Cholestatic Hepatitis C

Liver Transplantation - United States
doi 10.1002/lt.25027
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Challenging Hepatitis C-Infected Liver Transplant Patients

Hepatic Medicine: Evidence and Research
Hepatology
2016English

Hepatitis C Virus Genotypes in Liver Transplant Recipients

Transplantation
Transplantation
1997English

Severe Cholestatic Hepatitis C in Transplant Recipients: No Longer a Threat to Graft Survival

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2015English

Non-Invasive Assessment of Liver Fibrosis Through FibroMeter in Patients With Chronic Viral Hepatitis B and C

BMC Infectious Diseases
Infectious Diseases
2014English

SVR Is Associated With a Decreased Risk of Post-Transplant Diabetes Mellitus in Liver Transplant Recipients With Hepatitis C Related Liver Disease

Liver Transplantation
HepatologyTransplantationSurgery
2018English

Thrombotic Risk Factors and Extent of Liver Fibrosis in Chronic Viral Hepatitis

Gut
Gastroenterology
2003English

Editorial: Direct Anti-Viral Agents, Hepatitis C Virus Eradication, and Gut-Liver Axis-Another Mechanistic Piece to the Puzzle

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Sofosbuvir Plus Ledipasvir for Recurrent Hepatitis C in Liver Transplant Recipients

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Hepatitis C Viremic Donors for Hepatitis C Negative Liver Transplant Recipients: Ready for Prime Time?

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy